MedTrace Logo

Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section

NCT03587077 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2018-07-16

No results posted yet for this study

Summary

The aim of the work is to assess the effect of combined misoprostol 200 mcg and isosorbide mononitrate 40 mg versus misoprostol 200 mcg and placebo as local vaginal tablet on the successful IUD insertion.

Conditions

  • IUD Insertion Complication

Interventions

DRUG

Misoprostol

vaginal application

DRUG

Placebos

vaginal application

DRUG

isosorbide mononitrate

vaginal application

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohamad S. Abdellah, Prof. · Supervisor

  • Ihab M. El-Nashar, Prof. · Supervisor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2019-04-30
Completion
2019-05-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587077 on ClinicalTrials.gov